Literature DB >> 3877039

Androgen receptor levels and androgen contents in the prostate lobes of intact and testosterone-treated Noble rats.

S M Ho, D Damassa, P W Kwan, H S Seto, I Leav.   

Abstract

Plasma testosterone (T) levels were correlated with androgen receptors, tissue content of T, and 5 alpha-dihydrotestosterone (DHT) in the three anatomically-discrete prostate lobes of intact and castrated Noble (Nb) rats bearing T-filled silastic capsules. Differences in androgen receptor content and tissue androgen levels were observed among the three prostatic lobes of intact Nb rats. Total (cytosolic and nuclear) androgen receptor levels were highest in the ventral prostate followed by the dorsolateral and anterior prostate lobes. In the ventral and anterior prostate, androgen receptors were found to be equally distributed between cytosols and nuclear extracts, whereas in the dorsolateral prostate, androgen receptors were predominantly nuclear (cytosolic: nuclear = 1.5). The ventral prostate had the highest total androgen content and DHT was the major tissue androgen in all three lobes. The ratio of tissue DHT:T varied among the lobes; the highest value was observed in the dorsolateral prostate. The higher proportions of nuclear androgen receptor, as well as the elevated tissue DHT:T found in the dorsolateral prostate compared to other lobes, suggest that differences in the androgen activation process may exist between the dorsolateral prostate and other prostatic lobes. Despite lower plasma and tissue T levels, the DHT content, weight and cytodifferentiation in all lobes of T-treated castrated rats closely approximated the situation found in intact animals. Total androgen receptor levels were, however, elevated in all prostatic lobes of T-treated, castrated rats as compared to intact controls. These increases were primarily attributed to the augmented levels of androgen receptor in the nuclear extracts of the three prostate lobes. Exposure of the prostate to a constant level of T, produced by silastic implantation, might be responsible for the higher total androgen receptor levels and enhanced nuclear androgen receptor retention found in the prostates of T-treated, castrated rats.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877039     DOI: 10.1002/j.1939-4640.1985.tb00846.x

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  8 in total

1.  Androgen replacement therapy after prostate cancer treatment.

Authors:  Mohit Khera
Journal:  Curr Urol Rep       Date:  2010-11       Impact factor: 3.092

Review 2.  Androgens, aging, and prostate health.

Authors:  Karin Welén; Jan-Erik Damber
Journal:  Rev Endocr Metab Disord       Date:  2022-06-24       Impact factor: 6.514

3.  Effects of Testosterone on Benign and Malignant Conditions of the Prostate.

Authors:  Amin S Herati; Taylor P Kohn; Peter R Butler; Larry I Lipshultz
Journal:  Curr Sex Health Rep       Date:  2017-04-26

Review 4.  Current state of practice regarding testosterone supplementation therapy in men with prostate cancer.

Authors:  Jason R Kovac; Michael M Pan; Larry I Lipshultz; Dolores J Lamb
Journal:  Steroids       Date:  2014-07-27       Impact factor: 2.668

Review 5.  Serum testosterone level, testosterone replacement treatment, and prostate cancer.

Authors:  Ali Atan; Altug Tuncel; Suleyman Yesil; Derya Balbay
Journal:  Adv Urol       Date:  2013-09-18

6.  Sex Hormone Binding Globulin Modifies Testosterone Action and Metabolism in Prostate Cancer Cells.

Authors:  Huika Li; Thy Pham; Brett C McWhinney; Jacobus P Ungerer; Carel J Pretorius; Derek J Richard; Robin H Mortimer; Michael C d'Emden; Kerry Richard
Journal:  Int J Endocrinol       Date:  2016-11-20       Impact factor: 3.257

Review 7.  Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer.

Authors:  Jin Wook Kim
Journal:  Investig Clin Urol       Date:  2020-04-27

8.  Morphometric Analysis of Rat Prostate Development: Roles of MEK/ERK and Rho Signaling Pathways in Prostatic Morphogenesis.

Authors:  Wen-Yang Hu; Parivash Afradiasbagharani; Ranli Lu; Lifeng Liu; Lynn A Birch; Gail S Prins
Journal:  Biomolecules       Date:  2021-12-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.